• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Oligosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Oligosaccharides

Recent Advances in Glycogen Research: Focus on 9005-79-2 and 20mg/mL Glycogen Solution

Glycogen (CAS 9005-79-2) is a highly branched polysaccharide that serves as a critical energy reserve in animals, fungi, and bacteria. Recent studies have highlighted its significance in various biomedical applications, including drug delivery, diagnostic assays, and metabolic research. The 20mg/mL Glycogen Solution, a standardized preparation, has emerged as a valuable tool in these applications due to its consistent quality and performance. This research brief synthesizes the latest findings on glycogen (9005-79-2) and its applications, with a focus on the utility of 20mg/mL Glycogen Solution in contemporary research.

A key area of investigation has been the role of glycogen in metabolic disorders such as glycogen storage diseases (GSDs). Recent studies utilizing 20mg/mL Glycogen Solution have demonstrated its efficacy in in vitro models of GSD, where it serves as a substrate for enzymatic assays. For instance, research published in the Journal of Biological Chemistry (2023) employed this solution to evaluate the activity of recombinant glycogen-debranching enzymes, providing insights into potential therapeutic targets for GSDs. The standardized concentration of 20mg/mL ensured reproducibility across experiments, underscoring its importance in metabolic research.

In the field of nanotechnology, glycogen (9005-79-2) has garnered attention as a biocompatible material for drug delivery systems. A 2024 study in Biomaterials Science reported the development of glycogen-based nanoparticles using 20mg/mL Glycogen Solution as a precursor. The researchers noted that the solution's high purity and consistent molecular weight distribution were critical for achieving uniform nanoparticle size and stability. These nanoparticles demonstrated enhanced drug-loading capacity and targeted delivery in preclinical models, suggesting promising applications in cancer therapy.

Another significant advancement involves the use of 20mg/mL Glycogen Solution in diagnostic assays. A recent publication in Analytical Chemistry (2024) described a novel glycogen-based biosensor for detecting bacterial contamination in clinical samples. The biosensor leveraged the high binding affinity of glycogen (9005-79-2) to bacterial surface proteins, with the 20mg/mL concentration optimized for maximum sensitivity. This innovation highlights the versatility of glycogen solutions in developing rapid and accurate diagnostic tools.

Despite these advancements, challenges remain in the large-scale production and application of glycogen-based products. Variability in the branching structure of glycogen (9005-79-2) can influence its performance in different systems, necessitating rigorous quality control measures. The 20mg/mL Glycogen Solution addresses some of these challenges by providing a standardized product, but further research is needed to optimize its use across diverse applications.

In conclusion, recent research underscores the multifaceted utility of glycogen (9005-79-2) and the 20mg/mL Glycogen Solution in biomedical and chemical applications. From metabolic studies to drug delivery and diagnostics, these tools are enabling groundbreaking discoveries. Future studies should focus on refining glycogen-based technologies and exploring new applications, ensuring that this versatile polysaccharide continues to drive innovation in the life sciences.

• 40592-72-1(6-(Hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,5-triol)
• 57167-43-8(Xyloheptaose)
• 60582-98-1(alpha-Cyclodextrin hydrate)
• 58634-79-0(Maltododecaose)
• 18449-79-1(Methyl 3-O-α-D-galactopyranosyl-β-D-galactopyranoside)
• 107123-59-1(63-a-D-maltotriosyl-maltotriitol)
• 37331-89-8(beta-CYCLODEXTRIN)
• 870721-81-6(Dtxsid801020053)
• 21973-65-9(Methyl α-D-lactoside)
• 288252-77-7(O-α-D-Galactopyranosyl-(1→6)-O-α-D-galactopyranosyl-(1→6)-α-D-galactopyranose)